XantheJuliana

IP属地:未知
    • XantheJulianaXantheJuliana
      ·2022-11-03
      I posted a month ago this would happen. Been a host for 11 years on the site and have 5 listings in various states. Business is very firmly down and I think even as they acknowledge that they are soft peddling it a bit by mashing together growth in certain types of stays and locales so that the overall picture is muddied. Long term the company is a great investment but short term it's going to suffer.$Airbnb, Inc.(ABNB)$
      676评论
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-22
      The bargaining chips are scattered, the upward pressure is high, and it has to be adjusted several times. Wait and see.$TENCENT(00700)$
      1,027评论
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-22
      MS keeps their rating on MU and lifts the price target from $75 to $77 on "better than feared" pricing. With the stock trading at $89? This goes to show you that MS cannot just admit that they were wrong. How can you ever trust these organizations? Why would you invest with an organization that behaves like this? I can't respect an organization with no principles. It's OK to have an opinion, but when your opinion turns out to be wrong you need to "man up".$Micron Technology(MU)$ $Morgan Stanley(MS)$
      1,045评论
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-17
      JNJ sure lived up to the hype, “One and done.” 😬 “A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccines over Johnson & Johnson's (JNJ.N) shot, due to rare but sometimes fatal cases of blood clotting.” Just as big a lie as mRNA vaccines efficacy of 95% when they were approved. Now we know what big pharma knew then.....antibodies and protection peak at day 28 then start dropping like a rock.$Moderna, Inc.(MRNA)$ $Johnson & Johnson(JNJ)$
      926评论
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-16
      Sold out at 301. If I see a W bottom form I will buy back twice the shares I sold. If not there's thousands of other stocks to invest in. The money I made with the proceeds from the sale at 301 are already up 15 pct. Lesson here is you don't have to ride stocks down. That's why they call it trading.$PayPal(PYPL)$
      662评论
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-16
      Etherium and crypto is tanking again... Is Nvidia involved in crypto? Nvidia has taken some steps to silo its markets. Chief among them is the introduction of crypto-mining processors, or CMPs, which Nvidia has created exclusively for miners. A US$400 million chunk of second-quarter revenue will come from them, according to the company's projections$NVIDIA Corp(NVDA)$
      1,203评论
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-10
      these are old news, but still very relevant. Novavax preclinical study: ”In the monkey study, the researchers did not find any evidence of the virus in the noses of the animals.” Pfizer preclinical study: ”The BNT162b2 vaccination also cleared the nose of detectable viral RNA in 100% of the SARS-CoV-2 challenged rhesus macaques within 3 days after the infection” 0 days vs. 3 days. I think we have a winner! NVAX deserves a hold. $Novavax(NVAX)$ $Pfizer(PFE)$
      1,8871
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-10
      they controlled the volume and parked the buy orders! u win shorts! U can fall back now and go short another company! Let us eat$Pear Therapeutics(PEAR)$
      1,078评论
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-09
      If you think about it the CEO's of Pfizer and Moderna had a decision to make over a year ago as to how much mRNA to include in their vaccines. Both knew the facts....the greater the amount of mRNA in each shot the greater the efficacy but higher the risk of side effects (both short and long term). Pfizer chose 30mcg while MRNA chose 100mcg. Wonder why? Consider the fact before COVID Pfizer was a near 300B dollar company with multiple brands while Moderna wasn't even worth 8B with no history of sales. Who faced the greater risk if it turned out the side effects risks were greater than expected? Who stood to gain the most if they weren't? IMO both acted in a reasonable manner (Pfizer taking the conservative route and MRNA the more aggressive one) considering their status of the companies at
      6,5444
      举报
    • XantheJulianaXantheJuliana
      ·2021-12-09
      I’ve been to Indonesia, Singapore, and Malaysia and can tell you Grab is everywhere out there. A lot of scooters which is predominantly how folks get around out there. This is huge. Also, Uber attempted to have business in SEA and ended up selling what they had to Grab because they realized they couldn’t compete. It will take time and a bit of clean up on the business model but I wouldn’t worry about this investment at all. There is so much more potential in SEA as those economies are rising very fast and GRAB has a lot more growth opportunities still in SEA.$Grab Holdings(GRAB)$ $Uber(UBER)$
      1,939评论
      举报
       
       
       
       

      热议股票